Two Sigma Advisers
ONCS

Two Sigma Advisers’s OncoSec Medical Incorporated ONCS Stock Holding History

Two Sigma Advisers’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,071
Closed -$213K – 3024
2021
Q4 		$213K Sell
10,071
-6,356
-39% -$215K ﹤0.01% 2269
2021
Q3 		$770K Buy
16,427
+9,227
+128% +$467K ﹤0.01% 1736
2021
Q2 		$445K Buy
7,200
+2,100
+41% +$191K ﹤0.01% 1989
2021
Q1 		$535K Buy
5,100
+3,582
+236% +$490K ﹤0.01% 1996
2020
Q4 		$215K Buy
1,518
+719
+90% +$76.7K ﹤0.01% 2144
2020
Q3 		$59K Buy
+799
New +$62.3K ﹤0.01% 2314

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SM
Salzhauer Michael $212M AUM 20.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return